Laura Benjamin

Laura Benjamin

Company: Oncxerna

Job title: Chief Executive Officer


Panel Discussion: Incorporation of Artificial Intelligence into Clinical Development Strategy: Best Practices & Pitfalls 4:45 pm

• What are some potential advantages that AI can confer to clinical development programmes? • When might an AI algorithm work better than a traditional statistical approach as a diagnostic, and when might it be unnecessary or inappropriate? • What additional work or risks are involved in developing an AI-based algorithm to support clinical development?…Read more

day: Track A - Day 1 pm

Identifying Predictive Biomarkers for Immuno-Oncology Therapeutics 4:15 pm

• Given the large number of novel IO agents and combination clinical trials being run, what is needed to harmonize biomarkers for the medical community? • Where is progress being made in developing analytically and clinically validated assays? • What impact does new predictive biomarker identification have on commercial potential of novel therapeutics?Read more

day: Track A - Day 1 pm

Panel Discussion: Diversity & Inclusion in Precision Medicine 9:30 am

• In the fast-paced precision medicine industry where innovation is key, this panel discussion will shed light on the efforts of precision medicine leaders to create and maintain diverse and inclusive workplace cultures • With the exchange of experience and knowledge, all can tap in to the diverse talents and perspectives which propel innovations towards…Read more

day: Day One Morning

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.